C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2002
12/03/2002	US6489365 Ltb4-antagonistic compounds for treatment of inflammation, allergy or gastropathy induced by non-steroidal antiinflammatory agents in a warm-blooded animals
12/03/2002	US6489364 From l-mannonic-gamma-lactone intermediates; for prophylaxis of hiv/aids hiv
12/03/2002	US6489349 Treating an autoimmune disorder with an alkylamine substituted pyridine
12/03/2002	US6489344 For treatment diabetes in a human or animal subject
12/03/2002	US6489327 Tryptase inhibitors
11/2002
11/28/2002	WO2002094820A1 Crystalline salts of 2-(4-{2-[2-hydroxy-3-(2-thiophen-2-yl-phenoxy)-propylamino]-2-methyl-propyl}-phenoxy)-nicotinonitrile
11/28/2002	WO2002094815A1 Process for the production of quinazolines
11/28/2002	WO2002094813A1 Novel pyridyl cyanoguanidine compounds
11/28/2002	WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	WO2002094770A2 Aminoalcohol derivatives
11/28/2002	WO2002094767A2 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
11/28/2002	WO2002094766A1 Phthalamide derivative, agricultural or horticultural insecticide, and use thereof
11/28/2002	WO2002094765A2 Substituted aromatic amide derivative, intermediate thereof, agrohorticultural insecticide containing thereof and method for the use thereof
11/28/2002	WO2002094322A2 Combination medicament for treatment of neoplastic diseases containing cyanoguanidine ikk inhibitors and a second anti-neoplastic drug
11/28/2002	WO2002094261A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound
11/28/2002	WO2002094208A1 Novel couplers for use in oxidative hair dyeing
11/28/2002	WO2002078745A3 Use of mglur5 antagonists in the manufacture of a medicament in the treatment of autism, mental retardation, schizophrenia
11/28/2002	WO2002072518A3 Method for producing monocarbonyl compounds or biscarbonyl compounds or hydroxyl compounds
11/28/2002	WO2002070610A3 Novel reactive dyes and the use thereof for dyeing substrates containing nucleophilic groups
11/28/2002	WO2002048106A3 Isoindolin-1-one glucokinase activators
11/28/2002	WO2002044153A8 4-6-diphenyl pyridine derivatives as antiinflammatory agents
11/28/2002	WO2002009759A3 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
11/28/2002	WO2001092219A1 Glycinamides
11/28/2002	WO2001092214A1 Carbamic acid esters as inhibitors of factor xa
11/28/2002	US20020177711 Coordination polymerization catalyst
11/28/2002	US20020177708 (R)-chiral halogenated substituted N-benzyl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/28/2002	US20020177637 Polymers and oligomers, their synthesis, and electronic devices incorporating same
11/28/2002	US20020177613 4-substituted-3-substituted-amino-cyclobut-3-ene-1,2-diones and analogs thereof as novel potassium channel openers
11/28/2002	US20020177610 Hypolipidemics; treating obesity and disorders of lipid metabolism
11/28/2002	US20020177594 Inhibitors of histone deacetylase
11/28/2002	US20020177591 Central nervous system (CNS); diazabicyclo compounds such as 1,4-Diaza-bicyclo(3.2.2)nonane-4-carboxylic acid, 4-cyclohexyl-phenyl ester; CNS-penetrant alpha 7 nicotinic receptor agonist
11/28/2002	US20020177584 Single pot process for preparing metal picolinates from alpha pecoline
11/28/2002	US20020177578 3-hydroxy-4-methoxypyridine-2-carboxyamides N-substituted with a benzyl 9-member dilactone ring
11/28/2002	DE10124867A1 New substituted (hetero)aryl-alkenes or -alkynes, used as thrombin inhibitors, serine protease inhibitors, antithrombotic agents and intermediates
11/28/2002	DE10123574A1 New heterocyclylmethyl-substituted anthranilamide derivatives and analogs as KDR/FLT tyrosine kinase inhibitors, used for treating e.g. psoriasis, restenosis, leukemia, arthritis, eye or kidney disease or arteriosclerosis
11/28/2002	DE10123573A1 New anthranilamide derivatives and analogs containing heterocycle N-oxide group, as KDR/FLT tyrosine kinase inhibitors, used for e.g. treating psoriasis, restenosis, leukemia, arthritis, eye or kidney disease or arteriosclerosis
11/28/2002	CA2449442A1 Combination medicament for treatment of neoplastic diseases
11/28/2002	CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	CA2447671A1 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
11/28/2002	CA2447233A1 Process for the production of quinazolines
11/28/2002	CA2434036A1 Novel couplers for use in oxidative hair dyeing
11/28/2002	CA2410628A1 Carbamic acid esters
11/28/2002	CA2410627A1 Glycinamides
11/27/2002	EP1259588A2 Composition and method for bleaching a substrate
11/27/2002	EP1259492A1 Substituted piperazine derivatives as mtp inhibitors
11/27/2002	EP1259487A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
11/27/2002	EP1259486A1 Pyridine-amidines as modulators of p38 map kinase
11/27/2002	EP1259485A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
11/27/2002	EP1259484A1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion
11/27/2002	EP1259237A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
11/27/2002	EP1066260A4 Pyridine/picoline production process
11/27/2002	EP0975223A4 In-situ generation of zinc pyrithione
11/27/2002	EP0931064B1 Stabilised monomer composition
11/27/2002	EP0862557B1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS
11/27/2002	EP0777492A4 Combinatorial libraries of substrate-bound cyclic organic compounds
11/27/2002	EP0585267B1 Herpesvirus particle preparation and vaccine
11/27/2002	CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002	CN1382135A Amine and amide derivatives as ligands for neuropeptide YY5 receptor usefu in treatment of obesity and other disorders
11/26/2002	US6486357 Catalytic oxidation of alcohols using manganese oxides
11/26/2002	US6486327 Method for producing hydroxymethylpyridines
11/26/2002	US6486318 Single pot process for preparing metal picolinates from alpha picoline
11/26/2002	US6486184 1-(cyclopentyloxy-(3,4-dichloro- phenyl)-acetyl)-3-methyl-urea for example; use in treating hyperglycemia characteristic of all type ii diabetes
11/26/2002	US6486183 Antivirals
11/26/2002	US6486178 Indane derivatives
11/26/2002	US6486168 Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
11/26/2002	US6486165 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/22/2002	WO2003101942A1 Amidine substituted aryl and heteroaryl derivatives with an antithrombotic and factor xa inhibiting action
11/22/2002	WO2001090079A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
11/22/2002	CA2445571A1 Substituted aryl and heteroaryl derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
11/22/2002	CA2410304A1 Novel carbamates and ureas production and use thereof as endothelin receptor antagonists
11/21/2002	WO2002092576A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002	WO2002092574A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002	WO2002092569A1 Method for large-scale manufacture of dye for dye-sensitised solar cells
11/21/2002	WO2002092556A1 Sulfonamide derivatives
11/21/2002	WO2002092552A2 Benzamidoacetonitriles and their use as antiparasitics
11/21/2002	WO2002092550A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002	WO2002092087A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002	WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/21/2002	WO2002074310A3 Stabilized formulation of selective ligands of retinoic acid gamma-receptors
11/21/2002	WO2002072084A3 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity
11/21/2002	US20020173665 Use treating pain, urinary incontinence and bladder overactivity
11/21/2002	US20020173660 A gaseous mixture of methyl ethyl ketone, formaldehyde and ammonia is supplied over the zeolilte catalyst and reacted in gas phase to form di, tri or tetramethyl pyridine
11/21/2002	US20020173654 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor, and useful as viricides and antitumor agents
11/21/2002	US20020173508 Enzyme inhibitors; antiinflammatory agents, antiarthritic agents
11/21/2002	US20020173507 Antiproliferative agents; apoptosis; anticancer agents
11/21/2002	US20020173500 Hypotensive agents; antiischemic agents
11/21/2002	US20020173488 Boronic Ester and acid compounds, synthesis and uses
11/21/2002	US20020173469 Protease inhibitors
11/21/2002	US20020173419 Methods of polymerizing ethylene and styrene copolymers with substituted pyridyl amine catalysts and catalysts therefor
11/21/2002	US20020170594 --Metal Complex Having Beta-Diketonate, Process for Production Thereof, Photoelectric Conversion Element, and Photochemical Cell--
11/21/2002	DE10125294A1 New heterocyclylmethyl-substituted anthranilamide derivatives and analogs as KDR/FLT tyrosine kinase inhibitors, used for treating e.g. psoriasis, restenosis, leukemia, arthritis, eye or kidney disease or arteriosclerosis
11/21/2002	DE10125293A1 New anthranilamide derivatives and analogs containing heterocycle N-oxide group, as KDR/FLT tyrosine kinase inhibitors, used for e.g. treating psoriasis, restenosis, leukemia, arthritis, eye or kidney disease or arteriosclerosis
11/21/2002	CA2447416A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002	CA2447084A1 Benzamidoacetonitriles and their use as antiparasitics
11/21/2002	CA2446879A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002	CA2446747A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002	CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
11/21/2002	CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002	CA2443721A1 Sulfonamide derivatives
11/20/2002	EP1258473A1 Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient

1 ... 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 ... 633